Clinical trial
Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative…
NCT00001538 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001538 |
|---|---|
| Title | Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers |
| Official title | Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome, HIV Infection |
| Intervention type | Biological |
| Interventions | APL 400-003 |
| Enrollment | 41 |
| Start date | Mar 1, 1996 |
| Completion | Apr 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: